EBITDA* FY 2021E FY 2022E
Consensus 4,278 3,114
Max 5,698 5,648
Min 2,649 2,378
Target price (TP)* GBp
Consensus 647
Max 1000
Min 333
Recommendations of analysts
Broker Date Recommendation Target price, GBp
SOVA Capital 13-Aug-2021 hold 630
Veles Capital 12-Aug-2021 hold 549
BofA 6-Aug-2021 buy 770
VTB Capital 5-Aug-2021 buy 1000
Goldman Sachs 29-Jul-2021 sell 600
Alfabank 7-Jul-2021 hold 520
ATON 18-Jun-2021 buy 850
BCS 1-Jun-2021 hold 730
Morgan Stanley 28-May-2021 hold 650
Rencap 21-May-2021 buy 670
Sberbank CIB 13-May-2021 hold 333
UBS 29-Apr-2021 sell 505

* Consensus EBITDA and TP are calculated on the basis of the last six months of broker reports, while eliminating the highest and lowest estimates to calculate the average.

Last update: 16.08.2021

This document has been issued by EVRAZ plc for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various independent analysts regarding EVRAZ’s revenues, earnings and business development. Such estimates and forecasts cannot be independently verified by reason of their subjective nature. EVRAZ plc gives no guarantee, representation or warranty and is not responsible or liable in any way as to the accuracy and completeness of this document.